MICHAEL A. KLOBUCHAR

Corporate Board Profile

← Back to All Directors

REVVITY, INC.

Filing Date Source Excerpt
2024-03-13 In this role he leads the advancement and execution of Merck’s strategy, with additional responsibility for business development and information technology.
2025-03-12 Chief Operating Officer, Eikon Therapeutics, Inc., a pioneering biotechnology company.

Data sourced from SEC filings. Last updated: 2025-04-15